首页 > 最新文献

Journal of vascular surgery. Venous and lymphatic disorders最新文献

英文 中文
Complications in Thermal Ablation Therapies With Diseased Iliac Veins 病变髂静脉热消融治疗的并发症
IF 2.8 2区 医学 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-03-01 Epub Date: 2026-02-28 DOI: 10.1016/j.jvsv.2025.102390
Olga Bakayev MD , Paul Tenewitz BS , Aleha Syed BS , Melody Eckert MS , Prayna Bhatia MS , Rielyn Booker MS , Jonathan Mashieh DO , Hiren Walia OMS-III , Natalie Marks MD , Enrico Ascher MD , Anil Hingorani MD
{"title":"Complications in Thermal Ablation Therapies With Diseased Iliac Veins","authors":"Olga Bakayev MD , Paul Tenewitz BS , Aleha Syed BS , Melody Eckert MS , Prayna Bhatia MS , Rielyn Booker MS , Jonathan Mashieh DO , Hiren Walia OMS-III , Natalie Marks MD , Enrico Ascher MD , Anil Hingorani MD","doi":"10.1016/j.jvsv.2025.102390","DOIUrl":"10.1016/j.jvsv.2025.102390","url":null,"abstract":"","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":"14 2","pages":"Article 102390"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147395216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Total Endovenous Laser Ablation With 1940-nm Laser vs 1470-nm Laser: Superior Closure of Truncal Veins and Varicose Tributaries 4040nm激光与1470nm激光的全静脉内激光消融:截断静脉和静脉曲张的优势
IF 2.8 2区 医学 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-03-01 Epub Date: 2026-02-28 DOI: 10.1016/j.jvsv.2025.102435
Jan Szczepański MD
{"title":"Total Endovenous Laser Ablation With 1940-nm Laser vs 1470-nm Laser: Superior Closure of Truncal Veins and Varicose Tributaries","authors":"Jan Szczepański MD","doi":"10.1016/j.jvsv.2025.102435","DOIUrl":"10.1016/j.jvsv.2025.102435","url":null,"abstract":"","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":"14 2","pages":"Article 102435"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147395360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel In Vivo Rethrombosis Model for the Testing of Venoplasty Balloons 用于静脉成形术气球测试的新型体内再血栓模型
IF 2.8 2区 医学 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-03-01 Epub Date: 2026-02-28 DOI: 10.1016/j.jvsv.2025.102410
Oscar Moreno MD , Amber Clay RVT, RDCS , Catherine Luke LVT , Sabrina Rocco MS , Kate Micallef MS , Trevin Eggleston BA , Kiran Kumar BS , David Babcock BS , David Gordon MD , Daniel D. Myers DMV, MPH , Thomas Wakefield MD , Peter Henke MD , Andrea Obi MD
{"title":"Novel In Vivo Rethrombosis Model for the Testing of Venoplasty Balloons","authors":"Oscar Moreno MD , Amber Clay RVT, RDCS , Catherine Luke LVT , Sabrina Rocco MS , Kate Micallef MS , Trevin Eggleston BA , Kiran Kumar BS , David Babcock BS , David Gordon MD , Daniel D. Myers DMV, MPH , Thomas Wakefield MD , Peter Henke MD , Andrea Obi MD","doi":"10.1016/j.jvsv.2025.102410","DOIUrl":"10.1016/j.jvsv.2025.102410","url":null,"abstract":"","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":"14 2","pages":"Article 102410"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147395621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient-reported Outcomes after Thermal vs Nonthermal Ablation for Treatment of Lower Extremity Superficial Venous Disease 患者报告的热消融与非热消融治疗下肢浅静脉疾病后的结果
IF 2.8 2区 医学 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-03-01 Epub Date: 2026-02-28 DOI: 10.1016/j.jvsv.2025.102417
Ankita Katukota BS
{"title":"Patient-reported Outcomes after Thermal vs Nonthermal Ablation for Treatment of Lower Extremity Superficial Venous Disease","authors":"Ankita Katukota BS","doi":"10.1016/j.jvsv.2025.102417","DOIUrl":"10.1016/j.jvsv.2025.102417","url":null,"abstract":"","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":"14 2","pages":"Article 102417"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147395623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of adjuvant ultrasound-guided peri-ulcer foam sclerotherapy on venous leg ulcer recurrence:. Long-term outcomes of the PUFS trial 超声引导下溃疡周围泡沫硬化辅助治疗对下肢静脉性溃疡复发的影响。PUFS试验的长期结果
IF 2.8 2区 医学 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-03-01 Epub Date: 2026-02-28 DOI: 10.1016/j.jvsv.2025.102431
Rashad Bishara MD
{"title":"The impact of adjuvant ultrasound-guided peri-ulcer foam sclerotherapy on venous leg ulcer recurrence:. Long-term outcomes of the PUFS trial","authors":"Rashad Bishara MD","doi":"10.1016/j.jvsv.2025.102431","DOIUrl":"10.1016/j.jvsv.2025.102431","url":null,"abstract":"","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":"14 2","pages":"Article 102431"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147395902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment Outcomes of Lymphaticovenous Anastomosis for Lower Extremity Lymphedema With Prevention of Venous Reflux 淋巴-静脉吻合术治疗下肢淋巴水肿及预防静脉回流的疗效观察
IF 2.8 2区 医学 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-03-01 Epub Date: 2026-02-28 DOI: 10.1016/j.jvsv.2025.102437
Shinsuke Akita MD, PhD
{"title":"Treatment Outcomes of Lymphaticovenous Anastomosis for Lower Extremity Lymphedema With Prevention of Venous Reflux","authors":"Shinsuke Akita MD, PhD","doi":"10.1016/j.jvsv.2025.102437","DOIUrl":"10.1016/j.jvsv.2025.102437","url":null,"abstract":"","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":"14 2","pages":"Article 102437"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147396154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Proximal tumescence during treatment of saphenous veins with polidocanol endovenous microfoam provides successful ablation of larger veins and predicts reduced microfoam volume 聚多醇静脉内微泡沫治疗隐静脉时近端肿胀提供了大静脉的成功消融和预测微泡沫体积的减少。
IF 2.8 2区 医学 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-03-01 Epub Date: 2025-12-04 DOI: 10.1016/j.jvsv.2025.102362
Alexandra Natalie Ascher MD , Enrico Ascher MD , Anil Hingorani MD , John Fang DO
<div><h3>Background</h3><div>Perivenous tumescence with saline or a dilute lidocaine solution is used routinely for thermal ablation of refluxing superficial lower extremity veins to displace sensitive structures away from the thermal probe and provide better contact with the treated venous endothelium. In this study, we introduce an adjunctive technique of tumescence infiltration at the most efferent segment of refluxing saphenous veins treated with 1% polidocanol endovenous microfoam (PEM). We hypothesize that, by reducing the vein diameter, proximal tumescence (PT) prolongs apposition time of PEM to the endothelium by delaying venous outflow and microfoam propagation speed. We evaluated PT effects on vein closure and volume of PEM used as well as the incidence of superficial venous thrombosis and ablation-related thrombus extension (ARTE).</div></div><div><h3>Methods</h3><div>A single institution retrospective study was performed with PEM ablations for the above-knee great saphenous vein (GSV), below-knee GSV, and small saphenous vein (SSV) by two operators over a 12-month period. Duplex ultrasound (DUS) within 3 to 7 days after ablation followed by a serial surveillance DUS schedule were used to evaluate for vein closure, venous thrombosis, and ARTE per institutional protocol. Any treated vein segment found to be completely or partially patent with reflux after treatment was deemed an ablation failure. Demographics and outcomes of tumescent PEM (T-PEM) ablations were compared with nontumescent PEM (NT-PEM) ablations through univariate and generalized estimating equation modeling.</div></div><div><h3>Results</h3><div>Between June 2023 and May 2024, 183 adult patients (64 male, 119 female) treated with 1% PEM in 246 lower extremities (113 right, 133 left) met the study criteria. Nineteen patients without documented follow-up DUS examinations were excluded from this study. Overall, 293 ablations (23 above-knee SV, 199 below-knee GSV, 71 small saphenous vein) were performed with a mean PEM volume of 2.8 ± 0.6 mL per ablation with a combined closure rate of 91.8% (269 of 293). One hundred nineteen ablations (40.6%) were augmented with PT (mean tumescence volume, 6 ± 2.4 mL; range, 3-16 mL). Veins treated with T-PEM were significantly larger (mean vein diameter, 4.8 ± 1.3 mm) than veins treated with NT-PEM (mean vein diameter, 4.0 ± 0.9 mm; <em>P</em> < .001). There were no significant differences in patient age (<em>P</em> = .37), sex (<em>P</em> = .06), laterality (<em>P</em> = .29), preoperative Clinical-Etiology-Anatomy-Pathophysiology clinical severity scores (<em>P</em> = .34), PEM volume used (<em>P</em> = .09), venous thrombosis (<em>P</em> = .65), ARTE (<em>P</em> = .41), or rate of treatment success (<em>P</em> = .16) on univariate comparison of T-PEM and NT-PEM ablations. Generalized estimating equation regression predicts lower microfoam volume use with PT (B = −0.4; <em>P</em> = .003) and similar treatment success rates when correct
背景:常规使用生理盐水或稀释利多卡因溶液进行静脉周围肿胀,用于热消融回流的下肢浅静脉,以使敏感结构远离热探头,并提供更好的接触治疗静脉内皮。在这项研究中,我们介绍了一种辅助技术,即用1%聚多醇静脉内微泡沫(PEM)治疗回流性隐静脉最出段的肿胀浸润。我们推测,通过减小静脉直径,近端肿胀(PT)通过延迟静脉流出和微泡沫的传播速度延长了PEM与内皮的相对时间。我们评估了PT对静脉闭合的影响,所用PEM的体积以及浅静脉血栓形成(SVT)和消融相关血栓延伸(ARTE)的发生率。方法:一项单机构回顾性研究,由两名手术人员在12个月的时间内对膝关节上方大隐静脉(AK-GSV)、膝关节下方大隐静脉(BK-GSV)和小隐静脉(SSV)进行PEM消融。消融后3- 7天内进行双工超声检查(DUS),并按机构方案连续监测DUS计划评估静脉关闭、VT和ARTE。治疗后发现任何治疗静脉段完全或部分通畅并伴有反流,则视为消融失败。通过单变量和广义估计方程模型比较膨胀性PEM消融(T-PEM)与非膨胀性PEM消融(NT-PEM)的人口学特征和结果。结果:在2023年6月至2024年5月期间,在246条下肢(113条右侧,133条左侧)接受1% PEM治疗的183例成年患者(男性64例,女性119例)符合研究标准。19例无DUS随访记录的患者被排除在本研究之外。总体而言,共进行293例消融(23例AK-GSV, 199例BK-GSV, 71例SSV),每次消融的平均PEM体积为2.8cc (SD=0.6cc),合并闭合率为91.8%(293例中的269例)。191例(40.6%)消融经PT增强(平均肿胀体积= 6cc, SD=2.4cc,范围=3cc至16cc)。T-PEM治疗的静脉(平均静脉直径=4.8mm, SD=1.3mm)明显大于NT-PEM治疗的静脉(平均静脉直径=4.0mm, SD=0.9mm, p)。结论:近端肿胀是一种安全有效的PEM消融辅助手段,对于大小隐静脉具有高的中短期关闭率和低的ARTE发生率。PT与减少微泡沫体积的使用有关。
{"title":"Proximal tumescence during treatment of saphenous veins with polidocanol endovenous microfoam provides successful ablation of larger veins and predicts reduced microfoam volume","authors":"Alexandra Natalie Ascher MD ,&nbsp;Enrico Ascher MD ,&nbsp;Anil Hingorani MD ,&nbsp;John Fang DO","doi":"10.1016/j.jvsv.2025.102362","DOIUrl":"10.1016/j.jvsv.2025.102362","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;div&gt;Perivenous tumescence with saline or a dilute lidocaine solution is used routinely for thermal ablation of refluxing superficial lower extremity veins to displace sensitive structures away from the thermal probe and provide better contact with the treated venous endothelium. In this study, we introduce an adjunctive technique of tumescence infiltration at the most efferent segment of refluxing saphenous veins treated with 1% polidocanol endovenous microfoam (PEM). We hypothesize that, by reducing the vein diameter, proximal tumescence (PT) prolongs apposition time of PEM to the endothelium by delaying venous outflow and microfoam propagation speed. We evaluated PT effects on vein closure and volume of PEM used as well as the incidence of superficial venous thrombosis and ablation-related thrombus extension (ARTE).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;A single institution retrospective study was performed with PEM ablations for the above-knee great saphenous vein (GSV), below-knee GSV, and small saphenous vein (SSV) by two operators over a 12-month period. Duplex ultrasound (DUS) within 3 to 7 days after ablation followed by a serial surveillance DUS schedule were used to evaluate for vein closure, venous thrombosis, and ARTE per institutional protocol. Any treated vein segment found to be completely or partially patent with reflux after treatment was deemed an ablation failure. Demographics and outcomes of tumescent PEM (T-PEM) ablations were compared with nontumescent PEM (NT-PEM) ablations through univariate and generalized estimating equation modeling.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;Between June 2023 and May 2024, 183 adult patients (64 male, 119 female) treated with 1% PEM in 246 lower extremities (113 right, 133 left) met the study criteria. Nineteen patients without documented follow-up DUS examinations were excluded from this study. Overall, 293 ablations (23 above-knee SV, 199 below-knee GSV, 71 small saphenous vein) were performed with a mean PEM volume of 2.8 ± 0.6 mL per ablation with a combined closure rate of 91.8% (269 of 293). One hundred nineteen ablations (40.6%) were augmented with PT (mean tumescence volume, 6 ± 2.4 mL; range, 3-16 mL). Veins treated with T-PEM were significantly larger (mean vein diameter, 4.8 ± 1.3 mm) than veins treated with NT-PEM (mean vein diameter, 4.0 ± 0.9 mm; &lt;em&gt;P&lt;/em&gt; &lt; .001). There were no significant differences in patient age (&lt;em&gt;P&lt;/em&gt; = .37), sex (&lt;em&gt;P&lt;/em&gt; = .06), laterality (&lt;em&gt;P&lt;/em&gt; = .29), preoperative Clinical-Etiology-Anatomy-Pathophysiology clinical severity scores (&lt;em&gt;P&lt;/em&gt; = .34), PEM volume used (&lt;em&gt;P&lt;/em&gt; = .09), venous thrombosis (&lt;em&gt;P&lt;/em&gt; = .65), ARTE (&lt;em&gt;P&lt;/em&gt; = .41), or rate of treatment success (&lt;em&gt;P&lt;/em&gt; = .16) on univariate comparison of T-PEM and NT-PEM ablations. Generalized estimating equation regression predicts lower microfoam volume use with PT (B = −0.4; &lt;em&gt;P&lt;/em&gt; = .003) and similar treatment success rates when correct","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":"14 2","pages":"Article 102362"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145696280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of bleomycin polidocanol foam versus absolute ethanol for sclerotherapy of venous malformations 博来霉素聚多醇泡沫与无水乙醇硬化治疗静脉畸形的比较。
IF 2.8 2区 医学 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-03-01 Epub Date: 2025-11-06 DOI: 10.1016/j.jvsv.2025.102352
Jiayi Lai MD, Zian Xu MD, Hui Chen MD, PhD, Li Hu MD, PhD, Xiaoxi Lin MD, PhD, Xi Yang MD

Objective

The purpose of this study was to compare the efficacy and safety between two sclerosants for venous malformations (VMs), bleomycin polidocanol foam (BPF) and absolute ethanol (AE), and provide more clinical evidence for the application of BPF for VMs.

Methods

We conducted a retrospective study of 104 patients with VMs who had been treated with BPF and AE sclerotherapy. Patients were followed-up after treatment to assess clinical efficacy and complications. Clinical efficacy was independently evaluated by three experts based on pre- and post-treatment photos and magnetic resonance images. Complications were categorized according to the Society of Interventional Radiology Adverse Event Classification System.

Results

A total of 104 patients with VM were enrolled in this study, of which 53 (51%) received BPF sclerotherapy, and 51 (49%) received AE sclerotherapy. Most of the patients had head and neck VMs (n = 64; 62%), and the most common symptom was disfigurement. The number of sessions in the BPF group was significantly lower than in the AE group (1.5 vs 2.2; P < .05). The median treatment efficacy score was 3.0 for the BPF group and 2.7 for the AE group, with no significant difference between two groups. The median follow-up was 45 months for the BPF group and 33 months for the AE group, with no significant difference between two groups. Complications occurred in 11 patients in the BPF group and in 15 patients in the AE group, but there was no significant difference between the two groups. Mild adverse events occurred in 10 of 53 patients (19%) in the BPF group and 10 of 51 (20%) in the AE group. Moderate adverse events occurred in one patient (2%) in the BPF group and three patients (6%) in the AE group. Two patients (4%) in the AE group had nerve injury, evaluated as severe adverse events, whereas no patients in the BPF group did.

Conclusions

BPF has comparable treatment efficacy to AE in sclerotherapy for VMs. BPF showed a trend toward a lower rate of severe adverse events, although this difference was not statistically significant in our cohort. It could be an optimal sclerosant to treat VMs.
目的:比较博来霉素聚多醇泡沫(BPF)和无水乙醇(AE)两种硬化剂治疗静脉畸形(vm)的疗效和安全性,为BPF在vm中的应用提供更多临床依据。方法:我们对104例接受BPF和AE硬化治疗的vm患者进行了回顾性研究。治疗后随访患者,评估临床疗效及并发症。临床疗效由三位专家根据治疗前后照片和磁共振图像独立评估。并发症按照介入放射学会(SIR)不良事件分类系统进行分类。结果:104例VM患者入组,其中53例(51%)接受BPF硬化治疗,51例(49%)接受AE硬化治疗。大多数患者有头颈部vm (n=64, 62%),最常见的症状是毁容。BPF组的治疗次数明显低于AE组(1.5 vs 2.2)。结论:BPF在vm硬化治疗中的疗效与无水乙醇相当。BPF显示出严重不良事件发生率较低的趋势,尽管这种差异在我们的队列中没有统计学意义。它可能是治疗vm的最佳硬化剂。
{"title":"Comparison of bleomycin polidocanol foam versus absolute ethanol for sclerotherapy of venous malformations","authors":"Jiayi Lai MD,&nbsp;Zian Xu MD,&nbsp;Hui Chen MD, PhD,&nbsp;Li Hu MD, PhD,&nbsp;Xiaoxi Lin MD, PhD,&nbsp;Xi Yang MD","doi":"10.1016/j.jvsv.2025.102352","DOIUrl":"10.1016/j.jvsv.2025.102352","url":null,"abstract":"<div><h3>Objective</h3><div>The purpose of this study was to compare the efficacy and safety between two sclerosants for venous malformations (VMs), bleomycin polidocanol foam (BPF) and absolute ethanol (AE), and provide more clinical evidence for the application of BPF for VMs.</div></div><div><h3>Methods</h3><div>We conducted a retrospective study of 104 patients with VMs who had been treated with BPF and AE sclerotherapy. Patients were followed-up after treatment to assess clinical efficacy and complications. Clinical efficacy was independently evaluated by three experts based on pre- and post-treatment photos and magnetic resonance images. Complications were categorized according to the Society of Interventional Radiology Adverse Event Classification System.</div></div><div><h3>Results</h3><div>A total of 104 patients with VM were enrolled in this study, of which 53 (51%) received BPF sclerotherapy, and 51 (49%) received AE sclerotherapy. Most of the patients had head and neck VMs (n = 64; 62%), and the most common symptom was disfigurement. The number of sessions in the BPF group was significantly lower than in the AE group (1.5 vs 2.2; <em>P</em> &lt; .05). The median treatment efficacy score was 3.0 for the BPF group and 2.7 for the AE group, with no significant difference between two groups. The median follow-up was 45 months for the BPF group and 33 months for the AE group, with no significant difference between two groups. Complications occurred in 11 patients in the BPF group and in 15 patients in the AE group, but there was no significant difference between the two groups. Mild adverse events occurred in 10 of 53 patients (19%) in the BPF group and 10 of 51 (20%) in the AE group. Moderate adverse events occurred in one patient (2%) in the BPF group and three patients (6%) in the AE group. Two patients (4%) in the AE group had nerve injury, evaluated as severe adverse events, whereas no patients in the BPF group did.</div></div><div><h3>Conclusions</h3><div>BPF has comparable treatment efficacy to AE in sclerotherapy for VMs. BPF showed a trend toward a lower rate of severe adverse events, although this difference was not statistically significant in our cohort. It could be an optimal sclerosant to treat VMs.</div></div>","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":"14 2","pages":"Article 102352"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145476913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thrombectomy Reduces Pulmonary Embolism Mortality But Unequal Access and Outcomes Persist by Race and Income 取栓可降低肺栓塞死亡率,但因种族和收入的不同,取栓途径和结果存在不平等
IF 2.8 2区 医学 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-03-01 Epub Date: 2026-02-28 DOI: 10.1016/j.jvsv.2025.102434
Brett Cohen DO , Saran Singh MD , Nicholas Roma MD , Mary Sundo MD , Megan Pattoli DO , Mitchell Schwocho DO , Michael Durkin MD
{"title":"Thrombectomy Reduces Pulmonary Embolism Mortality But Unequal Access and Outcomes Persist by Race and Income","authors":"Brett Cohen DO ,&nbsp;Saran Singh MD ,&nbsp;Nicholas Roma MD ,&nbsp;Mary Sundo MD ,&nbsp;Megan Pattoli DO ,&nbsp;Mitchell Schwocho DO ,&nbsp;Michael Durkin MD","doi":"10.1016/j.jvsv.2025.102434","DOIUrl":"10.1016/j.jvsv.2025.102434","url":null,"abstract":"","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":"14 2","pages":"Article 102434"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147395359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Femoral Vein Pulsatility Signals Right-sided Cardiovascular Pathology: Implications for Echocardiographic Screening 股静脉搏动信号右侧心血管病理:超声心动图筛查的意义
IF 2.8 2区 医学 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-03-01 Epub Date: 2026-02-28 DOI: 10.1016/j.jvsv.2025.102401
Mouhammad Halabi MD , Michael Lee MD , Hassan Chamseddine MD , Alexander Shepard MD , Timothy Nypaver MD , Mitchell Weaver MD , Sachin Parikh MD , James Lee MD , Ryan Shelters , Loay Kabbani MD
{"title":"Femoral Vein Pulsatility Signals Right-sided Cardiovascular Pathology: Implications for Echocardiographic Screening","authors":"Mouhammad Halabi MD ,&nbsp;Michael Lee MD ,&nbsp;Hassan Chamseddine MD ,&nbsp;Alexander Shepard MD ,&nbsp;Timothy Nypaver MD ,&nbsp;Mitchell Weaver MD ,&nbsp;Sachin Parikh MD ,&nbsp;James Lee MD ,&nbsp;Ryan Shelters ,&nbsp;Loay Kabbani MD","doi":"10.1016/j.jvsv.2025.102401","DOIUrl":"10.1016/j.jvsv.2025.102401","url":null,"abstract":"","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":"14 2","pages":"Article 102401"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147395752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of vascular surgery. Venous and lymphatic disorders
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1